BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer

SIMPLE SUMMARY: Thyroid cancer is the most common endocrine malignancy. Patients with advanced thyroid cancers have poor survival rates, largely because of limited therapeutic options to combat their aggressive nature, creating a compelling need to identify novel therapeutic targets. We and others h...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Madison M., Espinoza, Veronica L., Hoff, Katelyn J., Pike, Laura A., Sharma, Vibha, Hofmann, Marie-Claude, Tan, Aik Choon, Pozdeyev, Nikita, Schweppe, Rebecca E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856535/
https://www.ncbi.nlm.nih.gov/pubmed/36672327
http://dx.doi.org/10.3390/cancers15020378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856535/
https://www.ncbi.nlm.nih.gov/pubmed/36672327
http://dx.doi.org/10.3390/cancers15020378

Ejemplares similares